cas 1226436-53-8|| where to buy N-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]-2-{2-[(pyrimidin-2-yl)amino]-1,3-thiazol-4-yl}acetamide

Produktname:N-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]-2-{2-[(pyrimidin-2-yl)amino]-1,3-thiazol-4-yl}acetamide

IUPAC Name:N-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]-2-{2-[(pyrimidin-2-yl)amino]-1,3-thiazol-4-yl}acetamide

: CAS：1226436-53-8; Molekulare Formel：C17H13N7OS2; Reinheit：95%+

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1226436-53-8 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1226436-53-8; Molekulare Formel:C17H13N7OS2; Schmelzpunkt:-; SMILES-Code:O=C(CC1=CSC(NC2=NC=CC=N2)=N1)NC1=NC(=CS1)C1=CC=CN=C1; Dichte:

: Katalognummer:CM999173; Molekulargewicht:395.46; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Thiazoles; Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.